Zobrazeno 1 - 10
of 58
pro vyhledávání: '"Matthew S. Ellis"'
Autor:
Matthew S. Ellis, Mance E. Buttram
Publikováno v:
Frontiers in Psychiatry, Vol 13 (2022)
Externí odkaz:
https://doaj.org/article/57342c075c704569a64066fe174cd1dc
Autor:
Sarah M. Hartz, Robert C. Culverhouse, Carrie M. Mintz, Matthew S. Ellis, Zachary A. Kasper, Patricia Cavazos-Rehg, Richard A. Grucza, Laura J. Bierut, Theodore J. Cicero
Publikováno v:
PLoS ONE, Vol 17, Iss 11 (2022)
Chronic pain increases risk for opioid overdose among individuals with opioid use disorder. The purpose of this study is to evaluate the relationship between recent overdose and whether or not chronic pain is active. 3,577 individuals in treatment fo
Externí odkaz:
https://doaj.org/article/b9dd11c8add4469db92343d2b4df79bd
Publikováno v:
Frontiers in Psychiatry, Vol 12 (2021)
Background: Stimulant use among individuals with opioid use disorder has recently increased, driven by changes in drug distribution channels. However, our understanding of polysubstance use is often limited by a need to provide targeted treatment to
Externí odkaz:
https://doaj.org/article/e66ec12a36454d11a4ae82e02fc0c967
Publikováno v:
Pharmaceuticals, Vol 14, Iss 12, p 1279 (2021)
While current opioid prescribing guidelines highlight a dose-response relationship between therapeutic management and overdose risk, other concurrent risk factors have also been identified. However, there is little data in assessing the relationship
Externí odkaz:
https://doaj.org/article/d3b48989f40843968b9a21c0408dcfaf
Publikováno v:
AIDS and Behavior. 27:875-879
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d53207336c999705d46273a701e457fc
https://doi.org/10.1007/s10461-022-03822-2
https://doi.org/10.1007/s10461-022-03822-2
Publikováno v:
Journal of addiction medicine.
Efforts to improve low naloxone uptake to mitigate the current opioid crisis have included coprescribing naloxone with opioid medications and, more recently, expansion through over-the-counter availability, the latter of which necessitates self-ident
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::21dd7ef318cb95327120334c7ed86be1
https://pubmed.ncbi.nlm.nih.gov/36148998
https://pubmed.ncbi.nlm.nih.gov/36148998
Publikováno v:
American journal of preventive medicine.
Coinciding with the rise in opioid use across the U.S., the rates of sexually transmitted infections have reached historically high levels, underscoring the need to understand multiple pathways of disease spread. Although prevention is often focused
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d8ec88cbbe6976c1811227044bcfbd6
https://pubmed.ncbi.nlm.nih.gov/36085260
https://pubmed.ncbi.nlm.nih.gov/36085260
Autor:
Janetta L Iwanicki, S Geoff Severtson, Heather McDaniel, Andrew Rosenblum, Chunki Fong, Theodore J Cicero, Matthew S Ellis, Steven P Kurtz, Mance E Buttram, Richard C Dart
Publikováno v:
PLoS ONE, Vol 11, Iss 12, p e0167499 (2016)
Therapeutic use and abuse of prescription opioids in the United States increased substantially between 1990 and 2010. The Centers for Disease Control estimated deaths related to pharmaceutical opioids reached nearly 19,000 in 2014. Of prescription op
Externí odkaz:
https://doaj.org/article/8f14151db5464d5b90fe6a3ad326dd0f
Publikováno v:
Drug and Alcohol Dependence. 242:109713
Prior research suggests a potential relationship between the nonmedical use of gabapentin and use of opioid agonist medications (OAMs), buprenorphine and methadone. However, this research has been limited in scope and understanding despite increases
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3095df17756b0e28bb2c0e43b00cdcfe
https://doi.org/10.1016/j.drugalcdep.2022.109713
https://doi.org/10.1016/j.drugalcdep.2022.109713
Publikováno v:
Drug and alcohol dependence. 234
As prescriptions for gabapentin have increased in recent years, nonmedical use and risk of adverse outcomes (e.g., hospitalizations and overdose) have been identified, particularly in association with opioids, including opioid agonist medications (OA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd6ab70ee378707ac0d54a12e2a9888d
https://pubmed.ncbi.nlm.nih.gov/35290917
https://pubmed.ncbi.nlm.nih.gov/35290917